ICOS and type 1 diabetes mellitus: To test this idea, we evaluated Tfh cells (CD4+ICOS+PD-1hiCXCR5+) in peripheral blood specimens from patients with ICI-T1DM versus patients who received ICI therapy but did not develop IrAEs.